Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 21;32(168):220238.
doi: 10.1183/16000617.0238-2022. Print 2023 Jun 30.

Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis

Tácito Zaildo  1 , Thayla Amorim Santino  2 , Gabriela Chaves  3 , Baldomero Antonio Kato da Silva  4 , João Carlos Alchieri  5 , Cecilia M Patino  6 , Sarah Leite  7 , Kleber Giovanni Luz  8 , Ricardo Oliveira Guerra  7 , Tito Hugo Soares da Penha  7 , Gabriel Rodrigues da Silva  7 , Ada Cristina Jácome  9 , Karolinne Souza Monteiro  10 , Karla Morganna Pereira Pinto de Mendonça  7
Affiliations
Review

Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis

Tácito Zaildo et al. Eur Respir Rev. .

Abstract

Aims: To summarise the evidence on barriers to and facilitators of population adherence to prevention and control measures for coronavirus disease 2019 (COVID-19) and other respiratory infectious diseases.

Methods: A qualitative synthesis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis and the Cochrane Effective Practice and Organization of Care: Qualitative Evidence Synthesis. We performed an electronic search on MEDLINE, Embase and PsycINFO from their inception to March 2023.

Results: We included 71 studies regarding COVID-19, pneumonia, tuberculosis, influenza, pertussis and H1N1, representing 5966 participants. The measures reported were vaccinations, physical distancing, stay-at-home policy, quarantine, self-isolation, facemasks, hand hygiene, contact investigation, lockdown, infection prevention and control guidelines, and treatment. Tuberculosis-related measures were access to care, diagnosis and treatment completion. Analysis of the included studies yielded 37 barriers and 23 facilitators.

Conclusions: This review suggests that financial and social support, assertive communication, trust in political authorities and greater regulation of social media enhance adherence to prevention and control measures for COVID-19 and infectious respiratory diseases. Designing and implementing effective educational public health interventions targeting the findings of barriers and facilitators highlighted in this review are key to reducing the impact of infectious respiratory diseases at the population level.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flow diagram.
FIGURE 2
FIGURE 2
Risk of bias assessment.
See this image and copyright information in PMC

References

    1. Kim HJ. Novel respiratory infectious diseases in Korea. Yeungnam Univ J Med 2020; 37: 286–295. doi:10.12701/yujm.2020.00633 - DOI - PMC - PubMed
    1. Jones KE, Patel NG, Levy MA, et al. . Global trends in emerging infectious diseases. Nature 2008; 451: 990–993. doi:10.1038/nature06536 - DOI - PMC - PubMed
    1. Cento JV, Barbaliscia S, Perno CF. Biotech innovations in the prevention of respiratory infectious diseases. New Microbiol 2017; 40: 155–160. - PubMed
    1. Lum L, Tambyah P. Outbreak of COVID-19 – an urgent need for good science to silence our fears? Singapore Med J 2020; 61: 55–57. doi:10.11622/smedj.2020018 - DOI - PMC - PubMed
    1. Bhadoria P, Gupta G, Agarwal A. Viral pandemics in the past two decades: an overview. J Fam Med Prim Care 2021; 10: 2745. doi:10.4103/jfmpc.jfmpc_2071_20 - DOI - PMC - PubMed